Recurrent Juvenile Nasopharyngeal Angiofibroma in a Young Boy: a Challenge to Treat
MetadataShow full item record
Nasopharyngeal angiofibroma constitutes 0.05% of all head and neck tumors. It is histologically benign, but locally invasive tumor with a high incidence of persistence and recurrence. Juvenile nasopharyngeal angiofibroma is still poorly understood with regard to its origin, greater incidence among males, and the specificity of its site of origin. Treatment of juvenile nasopharyngeal angiofibroma is mainly surgery. There are various surgical approach such as: transpalatine, transpalatine and sublabial, extended lateral rhinotomi or degloving approach and extracranial-intracranial and intratemporal fossa. Treatment options for angiofibroma nasopharyng include chemotherapy, hormone administration, radiation therapy, embolization. Today, these modalities are used only as occasional complementary treatment. We reported a case report with recurrent juvenile nasopharyngeal angiofibroma that occured in a 13 years old young boy and have been done previous operation.